📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Towards depersonalized abacavir therapy: chemical modification eliminates HLA-B*57 : 01-restricted CD8+ T-cell activation. (2015)

First Author: Naisbitt DJ

Attributed to: UoLiverpool Confidence in Concept 2013 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/qad.0000000000000867

PubMed Identifier: 26372480

Publication URI: http://europepmc.org/abstract/MED/26372480

Type: Journal Article/Review

Volume: 29

Parent Publication: AIDS (London, England)

Issue: 18

ISSN: 0269-9370